The Insurance Regulatory and Development Authority of India (IRDAI) has approved DSP Asset Managers’ proposal to acquire up to 11,53,14,606 equity shares of Niva Bupa Health Insurance Company Limited. The transaction strengthens DSP’s existing stake in the insurer and marks a significant development in Niva Bupa’s capital expansion plans.
Regulator Approves Share Acquisition Under Insurance Act
The approval was granted under Section 6A of the Insurance Act, 1938, along with the IRDAI (Registration, Capital Structure, Transfer of Shares and Amalgamation of Insurers) Regulations, 2024. In a regulatory disclosure dated November 13, 2025, Niva Bupa stated that IRDAI issued the approval letter on November 12, enabling DSP Asset Managers to move ahead with the proposed acquisition.
DSP to Deepen Investment in Niva Bupa
DSP Asset Managers, already an investor in Niva Bupa, will further increase its shareholding through this transaction. The additional equity acquisition underscores DSP’s long-term confidence in the insurer’s growth prospects amid rising demand for health coverage in India.
Disclosure Made in Line With SEBI Regulations
Niva Bupa confirmed that the filing was made in compliance with Regulation 30 of the SEBI (LODR) Regulations, 2015, and communicated to both the NSE and BSE. The insurer emphasized that the share acquisition aligns fully with applicable IRDAI guidelines governing ownership and capital structures of insurance entities.
Corporate Overview
Registered with IRDAI under Registration No. 145, Niva Bupa is among India’s leading private health insurance companies, offering comprehensive retail and corporate health solutions. Headquartered in Gurugram with a registered office in New Delhi, the company continues to focus on strengthening its capital base and expanding its footprint in the fast-growing health insurance sector.
Summary
IRDAI has approved DSP Asset Managers’ acquisition of 11.53 crore Niva Bupa shares, enabling the investment firm to increase its stake in the health insurer. The decision complies with the Insurance Act, 1938, and IRDAI’s 2024 regulations. Niva Bupa made the disclosure under SEBI’s LODR norms and stated that the move supports its broader capital-strengthening and growth objectives in India’s expanding health insurance market.
Disclaimer:
This article is intended solely for educational and informational purposes. The securities or companies mentioned are provided as examples and should not be considered as recommendations. Nothing contained herein constitutes personal financial advice or investment recommendations. Readers are advised to conduct their own research and consult a qualified financial advisor before making any investment decisions.
Investments in securities markets are subject to market risks. Please read all related documents carefully before investing.